Human Skin

16
Jan

Beyond clean claims, the emergence of skin microbiome in skin care

Integrating microbiome sciencewith cosmetic product developmentBeyond clean claims, the emergence of skin microbiome in skin careSkin care is entering a new era, one where skin biology, consumer insight, and smart formulation converge to shape innovation. At the center of this shift, the skin microbiome has emerged as a key focus, opening new pathways for cosmetic testing and research, driving the
Read more
5
Dec

Pilot studies – Local toxicity assesment

Request a toxicity pilot study plan and quote to evaluate local tolerance and immune effects in ex vivo human skin models.

22
Oct

App Note – Toxicity services for pharma, biotech and medical devices developers

Download this application note and discover 3 case studies. Refine formulations or assess local tolerance in human skin before clinical trials.

2
Apr

Advancing medical device development with ex vivo human skin

Advancing medical device development with ex vivo human skinMedical devices are evolving rapidly, becoming more sophisticated and diverse in their applications. From injectable drug delivery systems to wound dressings, wearable sensors, and microneedles, these innovations must undergo rigorous testing to ensure safety, functionality, and biocompatibility. However, as medical devices become more complex, so do the challenges associated with their preclinical
Read more
18
Mar

APPLICATION NOTE – NativeSkin® & Cosmetics

NativeSkin® & CosmeticsApplication NoteNativeSkin®: A Human Skin Model for Cosmetic Testing Discover NativeSkin®, an advanced ex vivo human skin model designed to provide a physiologically relevant and cruelty-free platform for cosmetic testing. This patented model preserves the structure, cellular complexity, and barrier function of real human skin, ensuring reliable assessments of efficacy (e.g., hydration, anti-aging, barrier repair) and safety (e.g.,
Read more
10
Feb

From human skin to human data: Advancing immunogenicity testing with human models

From human skin to human data: Advancing immunogenicity testing with human modelsIn a public workshop organized by the FDA-CRCG group, Dr. Nicolas Gaudenzio, CSO of Genoskin, introduced an innovative platform for assessing immune reactions in response to injected substances using human skin explants. His talk, titled "A new in vitro framework for assessing immunogenicity using comprehensive profiling of injectable human
Read more